tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Chimeric Therapeutics Lists Options on ASX to Boost Market Engagement
Company AnnouncementsChimeric Therapeutics Lists Options on ASX to Boost Market Engagement
16d ago
CHM
Chimeric Therapeutics Extends Entitlement Offer Deadline
PremiumCompany Announcements
Chimeric Therapeutics Extends Entitlement Offer Deadline
17d ago
CHM
Chimeric Therapeutics Announces Shareholder Structure Analysis
PremiumCompany Announcements
Chimeric Therapeutics Announces Shareholder Structure Analysis
18d ago
CHM
Chimeric Therapeutics Announces New ASX Quotation for Options
PremiumCompany Announcements
Chimeric Therapeutics Announces New ASX Quotation for Options
18d ago
CHM
Chimeric Therapeutics Launches $3.2 Million Entitlement Offer
PremiumCompany Announcements
Chimeric Therapeutics Launches $3.2 Million Entitlement Offer
26d ago
CHM
Chimeric Therapeutics Announces Proposed Issue of 25 Million Securities
PremiumCompany AnnouncementsChimeric Therapeutics Announces Proposed Issue of 25 Million Securities
1M ago
CHM
Chimeric Therapeutics Updates Proposed Securities Issue
Premium
Company Announcements
Chimeric Therapeutics Updates Proposed Securities Issue
1M ago
CHM
Chimeric Therapeutics Announces $3.2 Million Entitlement Offer
Premium
Company Announcements
Chimeric Therapeutics Announces $3.2 Million Entitlement Offer
1M ago
CHM
Chimeric Therapeutics Launches $3.2 Million Entitlement Offer to Advance Cancer Trials
PremiumCompany Announcements
Chimeric Therapeutics Launches $3.2 Million Entitlement Offer to Advance Cancer Trials
1M ago
CHM
Chimeric Therapeutics Expands Capital with New Share Issuance
PremiumCompany Announcements
Chimeric Therapeutics Expands Capital with New Share Issuance
1M ago
CHM
Chimeric Therapeutics to Present at NWR Virtual Healthcare Conference
PremiumCompany Announcements
Chimeric Therapeutics to Present at NWR Virtual Healthcare Conference
1M ago
CHM
Chimeric Therapeutics Resumes Trading with New Entitlement Offer
PremiumCompany Announcements
Chimeric Therapeutics Resumes Trading with New Entitlement Offer
2M ago
CHM
Chimeric Therapeutics Announces Proposed Securities Issue to Bolster R&D
PremiumCompany AnnouncementsChimeric Therapeutics Announces Proposed Securities Issue to Bolster R&D
2M ago
CHM
Chimeric Therapeutics Launches $3.2 Million Entitlement Offer to Advance Clinical Trials
Premium
Company Announcements
Chimeric Therapeutics Launches $3.2 Million Entitlement Offer to Advance Clinical Trials
2M ago
CHM
Chimeric Therapeutics Suspends Trading for Capital Raising Announcement
Premium
Company Announcements
Chimeric Therapeutics Suspends Trading for Capital Raising Announcement
2M ago
CHM
Chimeric Therapeutics Reports Increased Losses Amidst Asset Stabilization
PremiumCompany Announcements
Chimeric Therapeutics Reports Increased Losses Amidst Asset Stabilization
2M ago
CHM
Chimeric Therapeutics Secures $4.0m Funding for Innovative Cancer Therapy
PremiumCompany Announcements
Chimeric Therapeutics Secures $4.0m Funding for Innovative Cancer Therapy
2M ago
CHM
Chimeric Therapeutics Expands Capital with ASX Quotation
PremiumCompany Announcements
Chimeric Therapeutics Expands Capital with ASX Quotation
2M ago
CHM
Chimeric Therapeutics Issues New Shares to Boost Funding
PremiumCompany Announcements
Chimeric Therapeutics Issues New Shares to Boost Funding
2M ago
CHM
Chimeric Therapeutics Expands CHM CDH17 Clinical Trial with UChicago Medicine
PremiumCompany AnnouncementsChimeric Therapeutics Expands CHM CDH17 Clinical Trial with UChicago Medicine
2M ago
CHM
Chimeric Therapeutics Advances Clinical Trials and Strengthens Leadership
Premium
Company Announcements
Chimeric Therapeutics Advances Clinical Trials and Strengthens Leadership
3M ago
CHM
Chimeric Therapeutics Issues 55 Million Unquoted Securities
Premium
Company Announcements
Chimeric Therapeutics Issues 55 Million Unquoted Securities
4M ago
CHM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >